Auf dieser Seite
VOR Vor Biopharma Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 11, 2026
$18,69
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$6,5052-Wochen-Tief
$38,3152-Wochen-Hoch
Marktkapitalisierung (MRQ)
$1.02B
P/E
-0.4
EPS
$-70.50
Ihre Abzeichen
52W-Spanne
$6–$38
Analystenbewertung
BUY
Kursziel
$39
P/E
-0.4
ROE
83.4%
Nettogewinnmarge
·
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
VOR Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$18.69
Marktkapitalisierung (MRQ)
$1.02B
P/E
-0.4
EPS
$-70.50
Dividendenrendite
0.00%
ROE
83.4%
52W-Spanne
$7–$38
VOR Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 19. September 2025 | 1-for-20 | Umgekehrt |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
EPS$-70.502021-12-31 → 2025-12-31
Freier Cashflow$-144M2021-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | VOR | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -0.45-Jahres-Durchschnitt ≈-38.9 | ≈-38.9 | · | · | |
| K/B (MRQ) | -5.15-Jahres-Durchschnitt ≈24.2 | ≈24.2 | · | · | |
| Kurs / FCF (TTM) | -7.25-Jahres-Durchschnitt ≈-54.7 | ≈-54.7 | · | · | |
| Kurs / Cashflow (TTM) | -7.35-Jahres-Durchschnitt ≈-58.0 | ≈-58.0 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 57.35-Jahres-Durchschnitt ≈31.0 | ≈31.0 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | VOR | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| ROA | -229.3%5-Jahres-Durchschnitt ≈-84.5% | ≈-84.5% | -51.0% | Schwach | |
| ROE | 83.4%5-Jahres-Durchschnitt ≈-40.5% | ≈-40.5% | -33.0% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | VOR | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 19.15-Jahres-Durchschnitt ≈14.3 | ≈14.3 | 11.6 | Starke Liquidität | |
| Quick Ratio | 18.15-Jahres-Durchschnitt ≈14.0 | ≈14.0 | 9.8 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
Dividendenrendite0.00%
Ausschüttungsquote0.00%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
79.0%
Nächster Bericht
Nov 11, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 10, 2026 | $-1.16 | $-0.71 | -63.1% |
| 31. März 2026 | Mai 13, 2026 | $-5.11 | $-0.79 | -548.3% |
| 31. Dezember 2025 | $25.84 | $-1.69 | 1625.3% | |
| 30. September 2025 | $-3.33 | $-3.28 | -1.4% | |
| 30. Juni 2025 | $-43.80 | $-8.86 | -394.6% | |
| 31. März 2025 | $-5.20 | $-4.62 | -12.6% | |
| 31. Dezember 2024 | $-8.80 | $-5.77 | -52.5% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $322M | $93M | $94M | $65M | $48M | $32M | |
| SG&A Expense | $50M | $28M | $32M | $29M | $21M | $12M | |
| Operating Expenses | $372M | $121M | $126M | $93M | $69M | $43M | |
| Operating Income | $-372M | $-121M | $-126M | $-93M | $-69M | $-43M | |
| Interest Income | $6M | $4M | $8M | $1M | $119.0K | $29.0K | |
| Other Non-op | $-324M | $4M | $8M | $1M | $119.0K | $29.0K | |
| Net Income | $-696M | $-117M | $-118M | $-92M | $-69M | $-43M | |
| EPS (Basic) | $-70.50 | $-34.03 | $-1.75 | $-2.33 | $-2.10 | · | |
| EPS (Diluted) | $-70.50 | $-34.03 | $-1.75 | $-2.33 | $-2.10 | · | |
| Shares (Basic) | 9,871,866 | 3,435,533 | 67,191,973 | 39,551,420 | 33,433,214 | · | |
| Shares (Diluted) | 9,871,866 | 3,435,533 | 67,191,973 | 39,551,420 | 33,433,214 | · | |
| EBITDA | $-372M | $-121M | $-126M | $-93M | $-69M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $396M | $82M | $31M | $58M | $120M | $49M | |
| Short-term Investments | $59M | $10M | $106M | $173M | $88M | $0 | |
| Prepaid Expense | $1M | $4M | $3M | $4M | $5M | $467.0K | |
| Other Current Assets | $2M | $380.0K | $475.0K | $2M | $2M | $100.0K | |
| Current Assets | $458M | $97M | $141M | $237M | $214M | $49M | |
| PP&E (Net) | $533.0K | $7M | $10M | $13M | $7M | $5M | |
| PP&E (Gross) | $558.0K | $18M | $18M | $17M | $9M | $5M | |
| Accum. Depreciation | $25.0K | $11M | $8M | $5M | $2M | $726.0K | |
| Other Non-current Assets | $2M | $2M | $5M | $3M | $3M | $3M | |
| Total Assets | $464M | $143M | $198M | $299M | $243M | $76M | |
| Accounts Payable | $5M | $2M | $815.0K | $2M | $2M | $2M | |
| Accrued Liabilities | $20M | $13M | $11M | $8M | $6M | $6M | |
| Current Liabilities | $25M | $19M | $16M | $13M | $10M | $10M | |
| Capital Leases | $3M | $28M | $32M | $36M | $16M | $17M | |
| Total Liabilities | $628M | $46M | $47M | $49M | $26M | $28M | |
| Common Stock | $18.0K | $13.0K | $7.0K | $7.0K | $4.0K | $1.0K | |
| Retained Earnings | $-1.15B | $-457M | $-340M | $-222M | $-130M | $-61M | |
| AOCI | $41.0K | $22.0K | $-77.0K | $-770.0K | · | · | |
| Stockholders' Equity | $-164M | $97M | $151M | $251M | $216M | $-59M | |
| Liabilities + Equity | $464M | $143M | $198M | $299M | $243M | $76M | |
| Shares Outstanding | 38,720,196 | 6,238,799 | 3,395,072 | 65,996,138 | 37,174,741 | 505,074 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $19M | $10M | $13M | $11M | $4M | $1M | |
| Restructuring | $30M | · | · | · | · | · | |
| Operating Cash Flow | $-143M | $-100M | $-100M | $-85M | $-69M | $-36M | |
| CapEx | $941.0K | $229.0K | $1M | $8M | $4M | $4M | |
| Investing Cash Flow | $-49M | $97M | $71M | $-94M | $-92M | $-4M | |
| Stock Issued | $70M | $275.0K | $5M | $4M | · | · | |
| Net Stock Activity | $70M | $275.0K | $5M | $4M | · | · | |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | |
| Financing Cash Flow | $504M | $53M | $3M | $117M | $233M | $83M | |
| Net Change in Cash | $312M | $51M | $-26M | $-62M | $72M | $42M | |
| Free Cash Flow | $-144M | $-100M | $-101M | $-94M | $-73M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -229.3% | -68.6% | -47.4% | -34.0% | -43.3% | · | |
| ROE | 83.4% | -137.8% | -72.4% | -45.0% | -30.7% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 18.2 | 5.2 | 9.0 | 18.1 | 21.1 | · | |
| Quick Ratio | 18.1 | 4.9 | 8.8 | 17.6 | 20.4 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $-4.24 | $0.77 | $2.22 | $3.80 | $5.82 | · | |
| Cash Flow / Share | $-14.46 | $-1.45 | $-1.49 | $-2.15 | · | · | |
| Cash / Share | $10.24 | $0.66 | $0.46 | $0.87 | $3.22 | · | |
| EPS (TTM) | $-70.50 | $-34.03 | $-1.75 | $-2.33 | $-2.10 | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-696M | $-117M | $-118M | $-92M | $-69M | $-43M | |
| Market Cap | $506M | $2.77B | $3.06B | $8.78B | $8.64B | · | |
| P/E | -0.2 | -0.7 | -25.7 | -57.1 | -110.7 | · | |
| P/B | -3.1 | 28.7 | 20.3 | 35.0 | 39.9 | · | |
| P / Tangible Book | · | 28.7 | 20.3 | 35.0 | 39.9 | · | |
| P / Cash Flow | -3.5 | -27.8 | -30.5 | -103.1 | -124.9 | · | |
| P / FCF | -3.5 | -27.7 | -30.1 | -93.8 | -118.3 | · | |
| Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | |
| Earnings Yield | -539.0% | -153.3% | -3.9% | -1.8% | -0.90% | · | |
| Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | |
| Annual Payout | $0 | $0 | $0 | $0 | $0 | $0 |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $26M | $18M | $19M | $14M | $261M | $27M | $25M | $22M | $22M | $24M | $21M | $28M | $24M | $22M | $17M | $17M | |
| SG&A Expense | $22M | $18M | $17M | $14M | $13M | $7M | $6M | $7M | $7M | $8M | $7M | $8M | $8M | $9M | $8M | $7M | |
| Operating Expenses | $48M | $35M | $36M | $28M | $274M | $33M | $31M | $29M | $29M | $32M | $28M | $35M | $32M | $30M | $25M | $24M | |
| Operating Income | $-48M | $-35M | $-36M | $-28M | $-274M | $-33M | $-31M | $-29M | $-29M | $-32M | $-28M | $-35M | $-32M | $-30M | $-25M | $-24M | |
| Interest Income | $4M | $4M | $3M | $2M | $537.0K | $805.0K | $599.0K | $954.0K | $1M | $2M | $2M | $2M | $2M | $2M | $815.0K | $313.0K | |
| Other Non-op | $-15M | $-184M | $1.76B | $-785M | $-1.30B | $805.0K | $599.0K | $954.0K | $1M | $2M | $2M | $2M | $2M | $2M | $815.0K | $313.0K | |
| Net Income | $-63M | $-220M | $1.72B | $-813M | $-1.57B | $-32M | $-31M | $-28M | $-28M | $-31M | $-26M | $-33M | $-30M | $-28M | $-24M | $-24M | |
| EPS (Basic) | $-1.16 | $-5.11 | $63.95 | $-121.63 | $-251.24 | $-5.21 | $-25.12 | $-8.05 | $-0.41 | $-0.45 | $-0.38 | $-0.49 | $-0.45 | $-0.43 | $-0.51 | $-0.63 | |
| EPS (Diluted) | $-1.16 | $-5.11 | $63.95 | $-121.63 | $-251.24 | $-5.21 | $-25.12 | $-8.05 | $-0.41 | $-0.45 | $-0.38 | $-0.49 | $-0.45 | $-0.43 | $-0.51 | $-0.63 | |
| Shares (Basic) | 54,304,456 | 43,011,544 | · | 6,681,794 | 6,263,572 | 6,241,207 | · | 3,423,499 | 68,299,170 | 68,030,966 | · | 67,607,713 | 67,033,150 | 66,265,703 | · | 38,009,022 | |
| Shares (Diluted) | 54,304,456 | 43,011,544 | · | 6,681,794 | 6,263,572 | 6,241,207 | · | 3,423,499 | 68,299,170 | 68,030,966 | · | 67,607,713 | 67,033,150 | 66,265,703 | · | 38,009,022 | |
| EBITDA | $-48M | $-35M | · | $-28M | $-274M | $-33M | · | $-29M | $-29M | · | · | $-35M | $-32M | $-30M | · | $-24M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $108M | $170M | $396M | $160M | $191M | $50M | $82M | $53M | $76M | $45M | $31M | $45M | $32M | $42M | $58M | $61M | |
| Short-term Investments | $358M | $322M | $59M | $10M | $10M | $10M | $10M | $10M | $10M | $63M | $106M | $115M | $155M | $168M | $173M | $75M | |
| Prepaid Expense | $6M | $6M | $1M | $747.0K | $2M | $5M | $4M | $4M | $4M | $4M | $3M | $4M | $4M | $6M | $4M | $5M | |
| Other Current Assets | $3M | $3M | $2M | $1M | $449.0K | $297.0K | $380.0K | $285.0K | $272.0K | $507.0K | $475.0K | $667.0K | $539.0K | $459.0K | $2M | $2M | |
| Current Assets | $475M | $501M | $458M | $172M | $205M | $65M | $97M | $67M | $90M | $112M | $141M | $164M | $191M | $217M | $237M | $143M | |
| PP&E (Net) | $648.0K | $565.0K | $533.0K | $271.0K | $0 | $6M | $7M | $7M | $8M | $9M | $10M | $11M | $11M | $12M | $13M | $13M | |
| PP&E (Gross) | $738.0K | $618.0K | $558.0K | $272.0K | $0 | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $17M | $17M | $17M | |
| Accum. Depreciation | $90.0K | $53.0K | $25.0K | $1.0K | $0 | $12M | $11M | $11M | $10M | $9M | $8M | $7M | $6M | $5M | $5M | $4M | |
| Other Non-current Assets | $2M | $2M | $2M | $269.0K | $420.0K | $2M | $2M | $3M | $3M | $5M | $5M | $4M | $3M | $3M | $3M | $3M | |
| Total Assets | $481M | $507M | $464M | $176M | $205M | $109M | $143M | $116M | $142M | $167M | $198M | $223M | $251M | $278M | $299M | $206M | |
| Accounts Payable | $4M | $1M | $5M | $885.0K | $669.0K | $4M | $2M | $1M | $2M | $2M | $815.0K | $1M | $2M | $3M | $2M | $824.0K | |
| Accrued Liabilities | $20M | $15M | $20M | $18M | $58M | $9M | $13M | $9M | $8M | $7M | $11M | $10M | $7M | $5M | $8M | $6M | |
| Current Liabilities | $25M | $16M | $25M | $19M | $59M | $17M | $19M | $14M | $14M | $13M | $16M | $15M | $13M | $13M | $13M | $11M | |
| Capital Leases | $3M | $3M | $3M | $3M | $0 | $27M | $28M | $29M | $30M | $31M | $32M | $33M | $34M | $35M | $36M | $37M | |
| Total Liabilities | $681M | $657M | $628M | $2.40B | $1.71B | $43M | $46M | $43M | $44M | $44M | $47M | $48M | $47M | $47M | $49M | $48M | |
| Common Stock | $19.0K | $19.0K | $18.0K | $15.0K | $13.0K | $13.0K | $13.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $4.0K | |
| Retained Earnings | $-1.44B | $-1.37B | $-1.15B | $-2.88B | $-2.06B | $-489M | $-457M | $-426M | $-399M | $-371M | $-340M | $-314M | $-281M | $-251M | $-222M | $-198M | |
| AOCI | $-922.0K | $-706.0K | $41.0K | $12.0K | $14.0K | $23.0K | $22.0K | $68.0K | $-70.0K | $-87.0K | $-77.0K | $-280.0K | $-436.0K | $-174.0K | $-770.0K | $-1M | |
| Stockholders' Equity | $-200M | $-150M | $-164M | $-2.23B | $-1.51B | $66M | $97M | $73M | $98M | $123M | $151M | $175M | $204M | $230M | $251M | $159M | |
| Liabilities + Equity | $481M | $507M | $464M | $176M | $205M | $109M | $143M | $116M | $142M | $167M | $198M | $223M | $251M | $278M | $299M | $206M | |
| Shares Outstanding | 54,455,751 | 54,185,582 | 38,720,196 | 9,026,922 | 125,645,952 | 124,851,547 | 6,238,799 | 68,663,065 | 68,357,884 | 68,215,771 | 67,891,311 | 67,785,469 | 67,433,560 | 66,934,897 | 65,996,138 | 38,393,211 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $9M | $9M | $7M | $8M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $3M | $4M | $4M | $4M | $3M | |
| Restructuring | · | · | $0 | $-1M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-25M | $-38M | $-23M | $-54M | $-35M | $-31M | $-24M | $-23M | $-22M | $-30M | $-24M | $-28M | $-24M | $-24M | $-18M | $-19M | |
| CapEx | $120.0K | $48.0K | $314.0K | $244.0K | $152.0K | $231.0K | $72.0K | $34.0K | $9.0K | $114.0K | $111.0K | $465.0K | $399.0K | $94.0K | $321.0K | $298.0K | |
| Investing Cash Flow | $-37M | $-263M | $-49M | $-244.0K | $646.0K | $-230.0K | $-72.0K | $-34.0K | $53M | $44M | $10M | $41M | $14M | $6M | $-97M | $13M | |
| Stock Issued | · | · | $50M | $20M | $0 | $0 | $-22.0K | $111.0K | $-92.0K | $278.0K | $-15.0K | $392.0K | $579.0K | $4M | $106.0K | $4M | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | · | · | · | · | $4M | · | · | |
| Financing Cash Flow | $-106.0K | $75M | $308M | $22M | $175M | $-606.0K | $53M | $41.0K | $-31.0K | $96.0K | $25.0K | $176.0K | $218.0K | $3M | $112M | $4M | |
| Net Change in Cash | $-62M | $-227M | $236M | $-32M | $141M | $-32M | $29M | $-23M | $31M | $14M | $-14M | $13M | $-10M | $-15M | $-3M | $-2M | |
| Free Cash Flow | · | $-38M | · | · | · | $-31M | · | · | · | · | · | · | · | $-24M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -18.3% | -71.3% | · | -556.2% | -907.1% | -23.5% | · | -16.3% | -14.2% | · | · | -15.5% | -12.6% | -11.1% | · | -10.2% | |
| ROE | 7.4% | 520.6% | · | 75.5% | 223.6% | -34.4% | · | -22.2% | -18.4% | · | · | -19.9% | -15.8% | -13.4% | · | -12.2% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 19.1 | 31.1 | · | 9.2 | 3.5 | 3.9 | · | 4.7 | 6.5 | · | · | 10.7 | 15.1 | 17.2 | · | 12.9 | |
| Quick Ratio | 18.8 | 30.6 | · | 9.0 | 3.4 | 3.6 | · | 4.4 | 6.2 | · | · | 10.4 | 14.7 | 16.7 | · | 12.3 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-3.68 | $-2.78 | · | $-246.54 | $-11.98 | $0.53 | · | $1.06 | $1.43 | · | · | $2.58 | $3.03 | $3.44 | · | $4.13 | |
| Cash Flow / Share | · | $-0.89 | · | · | · | $-0.25 | · | · | · | · | · | · | · | $-0.37 | · | · | |
| Cash / Share | $1.98 | $3.13 | · | $17.78 | $1.52 | $0.40 | · | $0.77 | $1.11 | · | · | $0.66 | $0.48 | $0.63 | · | $1.58 | |
| EPS (TTM) | $-63.95 | $-314.03 | · | $-403.20 | $-289.62 | $-38.79 | · | $-9.29 | $-1.73 | $-1.82 | · | $-1.88 | $-2.02 | $-2.15 | · | $-2.30 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $628M | $-883M | · | $-2.45B | $-1.66B | $-119M | · | $-112M | $-118M | $-122M | · | $-116M | $-106M | $-98M | · | $-86M | |
| Market Cap | $1.00B | $967M | · | $440M | $4.07B | $1.79B | · | $961M | $1.37B | · | · | $2.87B | $4.17B | $7.20B | · | $3.06B | |
| P/E | -0.3 | -0.1 | · | -0.1 | -0.1 | -0.4 | · | -1.5 | -11.6 | -26.0 | · | -22.6 | -30.6 | -50.0 | · | -34.6 | |
| P/B | -5.0 | -6.4 | · | -0.2 | -2.7 | 27.1 | · | 13.2 | 13.9 | · | · | 16.4 | 20.4 | 31.3 | · | 19.3 | |
| P / Tangible Book | · | · | · | · | · | 27.1 | · | 13.2 | 13.9 | 26.3 | · | 16.4 | 20.4 | 31.3 | · | 19.3 | |
| P / Cash Flow | · | -25.3 | · | · | · | -57.7 | · | · | · | · | · | · | · | -296.8 | · | · | |
| Earnings Yield | -347.4% | -1760.3% | · | -827.6% | -893.9% | -270.1% | · | -66.4% | -8.6% | -3.8% | · | -4.4% | -3.3% | -2.0% | · | -2.9% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Nettoergebnis | $-696M | $-117M | $-118M | $-92M | $-69M |
| Verwässerte EPS | $-70.50 | $-34.03 | $-1.75 | $-2.33 | $-2.10 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 18.2 | 5.2 | 9.0 | 18.1 | 21.1 |
| Quick Ratio | 18.1 | 4.9 | 8.8 | 17.6 | 20.4 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-144M | $-100M | $-101M | $-94M | $-73M |
Institutionelle Eigentümer (13F) 104 Einreicher · $903.5M gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
104
Gehaltener Wert
$903.5M
Neue Positionen
39
Geschlossene Positionen
17
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 39 (+5 vs. Vorquartal) | 17 (+7 vs. Vorquartal) | 34 (+8 vs. Vorquartal) | 20 (+10 vs. Vorquartal) | +8.0M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| TCG Crossover Management, LLC | $104.441.366 | 5.673.078 | 11,56% | Aktien |
| FMR LLC | $90.800.863 | 4.932.149 | 10,05% | Aktien |
| FCPM III SERVICES B.V. | $75.800.487 | 4.117.354 | 8,39% | Aktien |
| BlackRock, Inc. | $63.847.850 | 3.468.107 | 7,07% | Aktien |
| Venrock Adviser, LLC | $55.998.047 | 3.041.719 | 6,20% | Aktien |
| STATE STREET CORP | $48.166.746 | 2.616.336 | 5,33% | Aktien |
| Frazier Life Sciences Management, L.P. | $46.833.917 | 2.543.939 | 5,18% | Aktien |
| RA CAPITAL MANAGEMENT, L.P. | $44.222.569 | 2.402.095 | 4,89% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $38.372.478 | 2.084.328 | 4,25% | Aktien |
| Caligan Partners LP | $35.440.465 | 1.925.066 | 3,92% | Aktien |
| Paradigm Biocapital Advisors LP | $32.217.500 | 1.750.000 | 3,57% | Aktien |
| GREAT POINT PARTNERS LLC | $31.297.000 | 1.700.000 | 3,46% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $19.563.726 | 1.062.469 | 2,17% | Aktien |
| NEXTBio Capital Management LP | $16.369.509 | 889.164 | 1,81% | Aktien |
| Nantahala Capital Management, LLC | $15.556.450 | 845.000 | 1,72% | Aktien |
| ADAR1 Capital Management, LLC | $12.530.325 | 680.626 | 1,39% | Aktien |
| Logos Global Management LP | $11.966.500 | 650.000 | 1,32% | Aktien |
| Rosalind Advisors, Inc. | $11.940.726 | 648.600 | 1,32% | Aktien |
| NAN FUNG TRINITY (HK) LTD | $11.902.986 | 646.550 | 1,32% | Aktien |
| BRAIDWELL LP | $10.550.845 | 573.104 | 1,17% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $10.285.704 | 558.702 | 1,14% | Aktien |
| VANGUARD GROUP INC | $10.074.870 | 770.250 | 1,12% | Aktien |
| UBS Group AG | $9.081.248 | 493.278 | 1,01% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $7.880.713 | 428.067 | 0,87% | Aktien |
| SPHERA FUNDS MANAGEMENT LTD. | $7.666.237 | 416.417 | 0,85% | Aktien |
| Woodline Partners LP | $6.990.700 | 379.723 | 0,77% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $6.266.101 | 340.364 | 0,69% | Aktien |
| GOLDMAN SACHS GROUP INC | $6.054.902 | 328.892 | 0,67% | Aktien |
| NORTHERN TRUST CORP | $6.052.141 | 328.742 | 0,67% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $5.535.961 | 300.704 | 0,61% | Aktien |
| Clearline Capital LP | $5.251.931 | 285.276 | 0,58% | Aktien |
| BANK OF AMERICA CORP /DE/ | $3.272.175 | 177.739 | 0,36% | Aktien |
| CITADEL ADVISORS LLC | $2.953.222 | 160.414 | 0,33% | Aktien |
| Eversept Partners, LP | $2.755.627 | 149.681 | 0,30% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2.234.937 | 121.398 | 0,25% | Aktien |
| Bank of New York Mellon Corp | $1.799.062 | 97.722 | 0,20% | Aktien |
| MARSHALL WACE, LLP | $1.760.788 | 95.643 | 0,19% | Aktien |
| Nuveen, LLC | $1.745.544 | 94.815 | 0,19% | Aktien |
| AXIOM INVESTORS LLC /DE | $1.695.653 | 92.105 | 0,19% | Aktien |
| XTX Topco Ltd | $1.521.494 | 82.645 | 0,17% | Aktien |
| Jump Financial, LLC | $1.305.066 | 70.889 | 0,14% | Aktien |
| Invesco Ltd. | $1.257.421 | 68.301 | 0,14% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.189.286 | 64.600 | 0,13% | Verkaufsoption |
| CITIGROUP INC | $1.162.224 | 63.130 | 0,13% | Aktien |
| MORGAN STANLEY | $1.133.338 | 61.561 | 0,13% | Aktien |
| RHUMBLINE ADVISERS | $1.059.081 | 57.528 | 0,12% | Aktien |
| ALPS ADVISORS INC | $1.012.513 | 54.998 | 0,11% | Aktien |
| D. E. Shaw & Co., Inc. | $1.006.493 | 54.671 | 0,11% | Aktien |
| JOHNSON & JOHNSON | $989.206 | 53.732 | 0,11% | Aktien |
| Rafferty Asset Management, LLC | $898.739 | 48.818 | 0,10% | Aktien |
Aktivisten & 5%+-Eigentümer 4 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×19 Einreichungen | 21. Juli 2026 | 19,90% | Änderung | Vorstandskampagne | SEC |
| ForGrowth III PA B.V., Forbion Growth Opportunities Fund III Cooperatief U.A., Forbion Growth III Management B.V. | 23. Dezember 2025 | 9,99% | Erste Einreichung | Vorstandskampagne | SEC |
| Reprogrammed Interchange LLC, Reid Hoffman ×9 Einreichungen | 17. Oktober 2025 | 17,60% | Änderung | · | SEC |
| 5AM Ventures VI, L.P., 5AM Partners VI, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Andrew J. Schwab, Kush Parmar ×3 Einreichungen | 9. Juli 2025 | 3,50% | Änderung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 25 Insider · 10 Führungskräfte · 16 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jean-Paul Kress | CEO and Chairman | 5. Dezember 2025 A | · | 0 | 0 | $0 |
| Robert Ang | PRESIDENT AND CEO | 6. Mai 2025 F | 911.318 | 0 | 0 | $0 |
| Sandesh Mahatme | CFO | 5. Dezember 2025 A | 0 | 0 | 0 | $0 |
| Han Wook Choi | Chief Financial Officer | 1. Mai 2025 F | 51.280 | 0 | 0 | $0 |
| Nathan D. Jorgensen | CHIEF FINANCIAL OFFICER | 6. Mai 2024 F | 189.403 | 0 | 0 | $0 |
| Qing Che Zuraw | Chief Development Officer | 5. Dezember 2025 A | 937.080 | 0 | 0 | $0 |
| Tirtha Chakraborty | Chief Sci Off & Head Tech Ops | 6. Mai 2025 F | 217.416 | 0 | 0 | $0 |
| Eyal C. Attar | CHIEF MEDICAL OFFICER | 13. Februar 2025 S | 126.625 | 0 | 0 | $0 |
| Amy Quinlan | Vice President of Finance | 6. November 2024 F | 50.312 | 0 | 0 | $0 |
| Christopher Slapak | Chief Medical Officer | 1. Februar 2022 A | · | 0 | 0 | $0 |
| David Zaccardelli | Direktor | 7. Juli 2026 A | · | 0 | 0 | $0 |
| Wouter Joustra | Direktor | 11. Juni 2026 A | · | 0 | 0 | $0 |
| Andrew David Levin | Direktor | 11. Juni 2026 A | · | 0 | 0 | $0 |
| Michel Detheux | Direktor | 11. Juni 2026 A | · | 0 | 0 | $0 |
| Fouad Namouni | Direktor | 11. Juni 2026 A | · | 0 | 0 | $0 |
| Alexander Cumbo | Direktor | 11. Juni 2026 A | · | 0 | 0 | $0 |
| Daniella Beckman | Direktor | 11. Juni 2026 A | · | 0 | 0 | $0 |
| Erez Kalir | Direktor | 11. Juni 2026 A | · | 0 | 0 | $0 |
| Sarah Burgess Reed | Direktor | 8. September 2025 A | · | 0 | 0 | $0 |
| Joshua Resnick | Direktor | 22. Mai 2025 A | · | 0 | 0 | $0 |
| Sven Ante Lundberg | Direktor | 22. Mai 2025 A | · | 0 | 0 | $0 |
| David Charles Lubner | Direktor | 22. Mai 2025 A | · | 0 | 0 | $0 |
| Matthew R Patterson | Direktor | 22. Mai 2025 A | · | 0 | 0 | $0 |
| Kush Parmar | Direktor | 14. Juni 2022 A | 1.766.634 | 0 | 0 | $0 |
| Alexandria Venture Investments, LLC | 10%-Eigentümer | 9. Februar 2021 C | 282.804 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 22 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,99% | 21.644 NS | 31. Juli 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,26% | 59.675 NS | 31. Juli 2026 | N-PORT |
| IWC · iShares Trust | 0,22% | 138.968 SH | 11. September 2026 | Täglich |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,19% | 28.491 SH | 2. Oktober 2026 | Täglich |
| FFSM · FIDELITY COVINGTON TRUST | 0,16% | 115.450 NS | 31. Juli 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,07% | 4.195 SH | 2. Oktober 2026 | Täglich |
| PWS · Pacer Funds Trust | 0,07% | 815 NS | 31. Juli 2026 | N-PORT |
| IWO · iShares Trust | 0,04% | 263.868 SH | 11. September 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,03% | 29.989 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,03% | 1.046.684 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,03% | 19.535 NS | 31. Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 234.796 SH | 19. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 20.868 SH | 2. Oktober 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 492.007 SH | 19. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 11.048 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 61.141 SH | 19. August 2026 | Täglich |
| WSML · iShares Trust | 0,01% | 2.468 SH | 11. September 2026 | Täglich |
| ITOT · iShares Trust | 0,00% | 67.560 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 13.099 SH | 11. September 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.550.885 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.390 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 117.140 SH | 11. September 2026 | Täglich |
VOR Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 13 Analysten
KAUF
Median-Ziel
$40.00
+114,0%
5 38,5%
Starker Kauf
6 46,2%
Kauf
2 15,4%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
8 Analysten · 2026-09-29Mittelwert-Ziel $39.00 +108,7%
← Unter allen Zielen
Aktueller Preis $18.69
Tief$27.00
Mittelwert$39.00
Hoch$50.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| VOR | $506M | -0.2 | · | · | 83.4% | · |
| REPL | $633M | -2.3 | · | · | -146.2% | · |
| MNKD | $1.75B | 283.5 | 22.2% | 1.7% | -11.1% | · |
| TRAX | · | · | · | · | · | · |
| BCAX | $953M | -6.7 | · | · | -33.0% | · |
| MGTX | $645M | -5.6 | 144.6% | -140.3% | 8062.2% | · |
| JANX | $833M | -7.5 | -5.5% | -1136.2% | -11.7% | · |
| AKTS | · | · | · | · | · | · |
| CGEM | $624M | -3.2 | · | · | -44.0% | · |
| ODTX | · | · | · | · | · | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 11, 2026